Abstract:Abstract Introduction Obstructive sleep apnea (OSA) has been known to be associated with increased cardiovascular, metabolic diseases and mortality. As few studies reported associated factors on relationship between OSA and mortality, we aimed to investigate all-cause mortality and associated factors in OSA patients. Methods We performed retrospective study in group of 1547 subjects who referred to the Center for Sleep and Chronobiology, Seoul National University Hospital, from June 2004 to December 2013. Subjects who had other sleep disorders including parasomnia, restless legs syndrome, possible periodic limb movement disorder (PLMI>15), narcolepsy, etc were excluded (N=331) and a total of 1216 subjects was included for analysis. Deaths out of final subjects that occurred up to December 31, 2020 from Statistics of Korea, the national bureau of statistics were examined. We divided subjects into four groups: no-sleep disorder (N=276, AHI< 5), mild (N=268, 5≤AHI< 15), moderate (N=275, 15≤AHI< 30) and severe OSA groups (N=397, AHI≥30). We employed cox proportional hazard regression analysis to estimate hazard ratios (HRs) against no-sleep disorder and 95% confidence intervals adjusted for age, sex, hypertension, diabetes, dyslipidemia and longest apnea duration on polysomnography. Results HR of all-cause mortality was increased in the severe, moderate and mild OSA groups (HR=5.515, 95% CI=1.337-22.425, p-value=0.017, HR=5.443, 95% CI=1.555-19.054, p-value=0.008, HR=4.179, 95% CI=1.305-13.382, p-value=0.016, respectively). Longest apnea duration showed a significant association with decreased mortality (HR=0.955, 95% CI=0.932-0.979, p-value< 0.001). Age was associated with increased mortality (HR=1.103, 95% CI=1.071-1.136, p-value< 0.001). However, sex, diabetes, hypertension and dyslipidemia showed no significant association with mortality (All p-values > 0.05). Conclusion Current results suggest increased mortality in patients with OSA. In particular, severity of OSA based on AHI was related with increased mortality. We found longest apnea duration was associated with decreased mortality as well. Previous notion on adverse effect of shorter apnea duration associated with frequent arousal might attribute to these results. Since CPAP compliance was not considered in this study, association between CPAP use and apnea duration also can be considered as another possible cause. We need further study to confirm the associated factors on mortality in OSA including apnea duration. Support (if any) National Research Foundation (RS-2023-00242754).

Sleep apnea is associated with reduced in-hospital mortality in patients admitted for acute heart disease

Sleep apnea in end-stage renal disease patients: Impact on cardiovascular and neurological outcomes

Sleep apnea, the risk of out-of-hospital cardiac arrest, and potential benefits of continuous positive airway pressure therapy: a nationwide study

Snoring Survivors: the impact of obstructive sleep apnoea and continuous positive airway pressure use on in-hospital mortality, length of stay and costs among patients hospitalised with acute cardiovascular disease - A retrospective analysis of 2016-2019 National Inpatient Sample Data

Inverse relationship of subjective daytime sleepiness to mortality in heart failure patients with sleep apnoea

Comorbid insomnia and sleep apnoea is associated with all-cause mortality

Sleep-disordered breathing and mortality: a prospective cohort study

0490 Sleep Apnea Severity Has a U-shaped Association with All-cause Mortality

Co-morbid insomnia and sleep apnoea is associated with increased hypertension risk in a middle-aged population

Prognostic effect of obstructive sleep apnea in acute coronary syndrome patients with heart failure

Sleep disordered breathing and in-hospital prognosis in acute myocardial infarction patients: a subset of the AMI-Sleep study

Survival and Risk Factors Associated with Mortality in Patients with Sleep Apnoea in Colombia: A Retrospective Cohort Study

Impact of obstructive sleep apnoea on cardiovascular outcomes and mortality in young adults with congenital heart anomalies: insights from the national inpatient sample (2019)

Age modifies the association between severe sleep apnea and all-cause mortality.

Effects of combined morbid insomnia and sleep apnea on long-term cardiovascular risk and all-cause mortality in elderly patients: a prospective cohort study

0465 Increased All-cause Mortality and Associated Factors in Korean OSA Patients

Trends in sleep apnea and heart failure related mortality in the United States from 1999 to 2019

Impact of Obstructive Sleep Apnea On In-Hospital Outcomes in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample

Influence of Comorbidity and Obesity on the Occurrence of Vascular Events in Obstructive Apnoea Treated with CPAP

The Link Between Obstructive Sleep Apnea and Cardiovascular Disease

Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial